This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Bcworld Pharm. Co., Ltd.. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Innovations of Sang Kyu Nam in Pharmaceutical Chemistry
Introduction
Sang Kyu Nam is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for producing imatinib base. With a total of 2 patents, his work is recognized for its potential impact on the commercial production of important pharmaceutical compounds.
Latest Patents
Sang Kyu Nam's latest patents focus on a novel method for preparing imatinib base. This method involves reacting 4-(4-methyl-piperazinomethyl)-benzoic acid with a 2,2'-dibenzothiazolyl disulfide derivative in the presence of a phosphine derivative. The process results in the formation of a novel thioester compound, which serves as a reaction intermediate for the preparation of imatinib base. This innovative approach allows for the production of imatinib base in higher yield and purity, making it a cost-effective solution for large-scale manufacturing.
Career Highlights
Sang Kyu Nam is currently associated with Bcworld Pharm. Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His expertise in the field has led to the development of methods that enhance the efficiency and effectiveness of drug production.
Collaborations
Throughout his career, Sang Kyu Nam has collaborated with talented individuals such as Hearan Suh and Jong Sun Lee. These partnerships have contributed to the successful development of his patented methods and have fostered a collaborative environment for innovation.
Conclusion
Sang Kyu Nam's contributions to pharmaceutical chemistry, particularly through his innovative methods for producing imatinib base, highlight his role as a significant inventor in the field. His work not only advances scientific knowledge but also has practical implications for the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile